Urinary Incontinence Clinical Trials

Find Urinary Incontinence Clinical Trials Near You

A Randomized Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Status: Recruiting
Location: See all (7) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a multicentered, double-blind, randomized controlled, surgical trial of 358 women with inadequate symptom relief of stress urinary incontinence (SUI) or stress predominant mixed urinary incontinence (MUI) after conservative care. The Primary Aim is to determine the comparative effectiveness (as defined by much or very much better on PGI-I) of transurethral bulking agent (TBA) \[for 1 or 2 injections in 12 months\] vs. single-incision sling (SIS) 12 months after treatment intervention in women with predominant stress urinary incontinence (SUI).

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 21
Healthy Volunteers: f
View:

• Women ≥ 21 years

• For \> 3 months, bothersome SUI (response of somewhat, moderately, or quite a bit) without UUI or stress-predominant MUI. For those with equal bother of UUI and SUI, clinician determination that SUI is more severe/significant than UUI is required.

• A positive cough stress test on standardized non-invasive testing or urodynamic SUI within the past 18 months.

• Normal PVR \< 150 mL

• Candidate for either study procedure as determined by treating surgeon

• Available for up to 3 years.

• Agrees to randomization.

Locations
United States
California
University of California at San Diego
RECRUITING
La Jolla
Kaiser Permanente -- San Diego
RECRUITING
San Diego
Illinois
University of Chicago
RECRUITING
Chicago
North Carolina
Duke University, Duke Division of Urogynecology and Reconstructive Pelvic Surgery
RECRUITING
Durham
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Rhode Island
Brown/ Women and Infants Hospital of Rhode Island, Division of Urogynecology and Reconstructive Pelvic Surgery
RECRUITING
Providence
Texas
University of Texas Southwestern Medical Center
RECRUITING
Dallas
Time Frame
Start Date: 2024-08-28
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 358
Treatments
Active_comparator: Solyx Single-incision Sling
Solyx Single-incision Sling
Active_comparator: Bulkamid Transurethral Bulking Agent
Bulkamid Transurethral Bulking Agent
Sponsors
Collaborators: University of Pennsylvania, University of California, San Diego, RTI International, Duke University, University of Chicago, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Kaiser Permanente, University of Texas Southwestern Medical Center, Women and Infants Hospital of Rhode Island
Leads: NICHD Pelvic Floor Disorders Network

This content was sourced from clinicaltrials.gov